Hanson K A, Heidrick M L
Department of Biochemistry, University of Nebraska Medical Center, Omaha 68198-4525.
Int J Immunopharmacol. 1991;13(6):669-76. doi: 10.1016/0192-0561(91)90179-b.
Previously we determined that levamisole (LMS), when stored for a period of time, breaks down to three degradation products at neutral and alkaline pH. At low concentrations (10(-6) M), Product 1 inhibits the lymphocyte response to concanavalin A (Con A). Product 2 enhances the response and Product 3 has no effect. At higher concentrations (10(-5) M) all three products inhibit the response. To determine if these products are formed in culture media under culture conditions (e.g. in RPMI-1640 bicarbonate buffered medium, 37 degrees C, pH 7.0-7.5, during a 72 h culture period), we added freshly prepared LMS solutions to culture media with and without lymphocytes present and maintained the pH at 7.0, 7.25 or 7.5 by varying the amount of CO2 present. Periodically over a 72 h period, aliquots of the media were removed and analyzed for the presence of LMS and the three degradation products. Within 4 h, two of the degradation product began to form in culture media with or without lymphocytes present. Product No. 1, 3-(2-mercaptoethyl)-5-phenylimidazolidine-2-one or dl-2-oxy-3-(2-mercaptoethyl)-5-phenylimidazolidine (OMPI), which inhibits the lymphocyte response to concanavalin A (Con A) at concentrations above 0.4 micrograms/ml, was formed at pH 7.0, 7.25 and 7.5, but the compound did not reach inhibitory concentrations in the lymphocyte cultures during the 72 h culture period. Product No. 2, 6-phenyl-2,3-dihydroimidazo (2,1-b) thiazole, which enhances the Con A response between concentrations of 0.5 and 10 micrograms/ml, was detected at concentrations between 2.5 and 3.5 micrograms/ml at pH 7.25 and 7.5. Product 2 was not detected in cultures at pH 7.0 and subsequently when we cultured lymphocytes with freshly prepared LMS and maintained the pH at 7.0, no significant enhancement of the Con A response was observed.(ABSTRACT TRUNCATED AT 250 WORDS)
此前我们确定,左旋咪唑(LMS)在储存一段时间后,在中性和碱性pH条件下会分解为三种降解产物。在低浓度(10⁻⁶ M)时,产物1抑制淋巴细胞对刀豆球蛋白A(Con A)的反应。产物2增强该反应,而产物3无作用。在较高浓度(10⁻⁵ M)时,所有三种产物均抑制该反应。为了确定这些产物是否在培养条件下(例如在RPMI - 1640碳酸氢盐缓冲培养基中,37℃,pH 7.0 - 7.5,在72小时培养期内)在培养基中形成,我们将新制备的LMS溶液添加到有或无淋巴细胞的培养基中,并通过改变二氧化碳含量将pH维持在7.0、7.25或7.5。在72小时内定期取出培养基 aliquots 并分析LMS和三种降解产物的存在情况。在4小时内,无论有无淋巴细胞,两种降解产物开始在培养基中形成。产物1,3 -(2 - 巯基乙基)- 5 - 苯基咪唑烷 - 2 - 酮或dl - 2 - 氧代 - 3 -(2 - 巯基乙基)- 5 - 苯基咪唑烷(OMPI),在浓度高于0.4微克/毫升时抑制淋巴细胞对刀豆球蛋白A(Con A)的反应,在pH 7.0、7.25和7.5时形成,但在72小时培养期内该化合物在淋巴细胞培养物中未达到抑制浓度。产物2,6 - 苯基 - 2,3 - 二氢咪唑并(2,1 - b)噻唑,在浓度为0.5至10微克/毫升之间增强Con A反应,在pH 7.25和7.5时浓度在2.5至3.5微克/毫升之间被检测到。在pH 7.0的培养物中未检测到产物2,随后当我们用新制备的LMS培养淋巴细胞并将pH维持在7.0时,未观察到Con A反应有明显增强。(摘要截短至250字)